Phase 1b Study of Pegylated Liposomal Doxorubicin and Pembrolizumab in Endocrine-resistant Breast Cancer
Clinical trial NCT03591276 · RECRUITING
Trial details
- NCT number
- NCT03591276
- Sponsor
- Shaare Zedek Medical Center
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-18
- Primary completion
- 2021-04-15
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.